General Description

AbbVie

Youtube Subscribe

Ticker: ABBV

Sector: Biotechnology

Extended Summary

AbbVie

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Related Results

March 17, 2024 3:57 (London Time)

AbbVie

For the current quarter, Abbvie is expected to post earnings of $2.34 per share, indicating a change of -4.9% from the year-ago quarter. For next fi…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9463

MarketCap: 314,220,281,098.0

High: 180.58 Low: 177.54

Open: 179.84 Close: 177.88 Change: -1.96

March 08, 2024 1:41 (London Time)

AbbVie

AbbVie Inc. closed the most recent trading day at $180.57, moving -0.27% from the previous trading session. Dupixent, the megablockbuster immunology…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9678

MarketCap: 319,837,666,380.0

High: 182.42 Low: 179.54

Open: 182.19 Close: 180.57 Change: -1.62

February 23, 2024 5:53 (London Time)

AbbVie

Richard Gonzalez, who has led the company since it spun out from Abbott Laboratories in 2013, is retiring from the role. He will be replaced by the …

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9814

MarketCap: 312,224,166,203.0

High: 177.34 Low: 173.14

Open: 174.78 Close: 176.75 Change: 1.97

February 13, 2024 23:24 (London Time)

AbbVie

AbbVie (ABBV) stock is down -0.12% while the S&P 500 has fallen -1.15% as of 11:57 AM on Tuesday, Feb 13. The pharmaceutical giant had expected to t…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9477

MarketCap: 305,561,561,452.0

High: 175.2 Low: 171.96

Open: 174.46 Close: 173.29 Change: -1.17

February 05, 2024 9:37 (London Time)

AbbVie

Revenues of $54.32 billion, down 5.9% year over year. Sales of oral migraine drug Ubrelvy were $234 million, up 18.9%.

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9738

MarketCap: 297,793,196,800.0

High: 172.85 Low: 165.23

Open: 169.42 Close: 168.67 Change: -0.75

January 28, 2024 9:04 (London Time)

AbbVie

AbbVie broke ground on a $223 million expansion of its Singapore manufacturing facility. The project is expected to create more than 100 new jobs an…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9826

MarketCap: 290,254,352,012.0

High: 165.86 Low: 163.5

Open: 165.27 Close: 164.4 Change: -0.87

January 26, 2024 19:24 (London Time)

AbbVie

AbbVie broke ground on a $223 million expansion of its Singapore manufacturing facility. The project is expected to create more than 100 new jobs. T…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.4019

MarketCap: 291,543,194,329.0

High: 165.81 Low: 163.5

Open: 165.27 Close: 164.17 Change: -1.1

January 18, 2024 6:40 (London Time)

AbbVie

S&P Futures 4,771.25 0.00 (0.00%) Dow Futures 37,447.00 -11.00 (-0.03%) Nasdaq Futures 16,880.50 +10.75 (+0.75%) Russell 2000 Futures 1,925.80 +0.80…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9875

MarketCap: 286,087,683,698.0

High: 162.95 Low: 161.52

Open: 161.75 Close: 162.04 Change: 0.29

January 17, 2024 23:13 (London Time)

AbbVie

AbbVie Inc. stock falls t Tuesday, underperforms market - marketwatch.com. In 2022, Abbvies revenue was $58.05 billion.

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9118

MarketCap: 285,098,982,743.0

High: 162.95 Low: 161.52

Open: 161.75 Close: 162.04 Change: 0.29

January 12, 2024 2:55 (London Time)

AbbVie

Illinois-based drugmaker is not seeing any evidence of sales erosion. Forward dividend yield for AbbVie stock now stands at 3.82%, way below its pre…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9603

MarketCap: 291,119,465,348.0

High: 165.12 Low: 163.09

Open: 164.25 Close: 163.78 Change: -0.47

December 30, 2023 4:56 (London Time)

AbbVie

HSBC downgraded shares of AbbVie from a buy rating to a hold rating. HSBC downgrades shares of ABbV to hold rating on Monday morning. ABbvie possess…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9633

MarketCap: 273,605,334,132.0

High: 155.21 Low: 154.41

Open: 154.54 Close: 154.97 Change: 0.43

December 27, 2023 17:34 (London Time)

AbbVie

AbbVie Inc. has a solid track record of paying dividends. In the last five years, earnings per share has shrunk at approximately 5.3% per annum. The…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9005

MarketCap: 272,987,396,035.0

High: 154.97 Low: 153.72

Open: 154.05 Close: 154.51 Change: 0.46

December 22, 2023 0:58 (London Time)

AbbVie

AbbVie inc. stock rises th Thursday, still underperforms market. The company also started offering healthcare advocacy to all its US employees to he…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.34

MarketCap: 267,814,371,391.0

High: 152.91 Low: 151.29

Open: 152.05 Close: 152.59 Change: 0.54

December 18, 2023 4:27 (London Time)

AbbVie

AbbVie Inc. is a pharmaceutical firm with a strong exposure to immunology and oncology. The company announced today that adult patients with relapse…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9686

MarketCap: 271,963,384,330.0

High: 155.89 Low: 153.11

Open: 154.74 Close: 154.04 Change: -0.7

December 07, 2023 2:14 (London Time)

AbbVie

AbbVie is in talks to pay around $45 per share for Cerevel Therapeutics. Cerevel will specifically beef up AbbVsies portfolio for psychiatric and ne…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9661

MarketCap: 263,097,858,120.0

High: 147.07 Low: 144.73

Open: 144.79 Close: 146.38 Change: 1.59

November 27, 2023 5:00 (London Time)

AbbVie

Upadacitinib (RINVOQ®) Met the Primary Endpoint in Phase 2 Clinical Trial of Vitiligo. Upadadacinib has a market cap of $244.82 billion.

Sector: Biotechnology

Ticker: ABBV

Sentiment: -0.8126

MarketCap: 244,827,074,170.0

High: 140.08 Low: 138.46

Open: 140.0 Close: 138.67 Change: -1.33

November 07, 2023 4:50 (London Time)

AbbVie

AbbVie Inc. is celebrating the fifth annual BOTOX® Cosmetic (onabotulinumtoxinA) Day is Back Like Never Before. The company raised its annual profit…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.902

MarketCap: 249,293,883,845.0

High: 142.37 Low: 140.98

Open: 141.89 Close: 141.2 Change: -0.69

November 07, 2023 0:05 (London Time)

AbbVie

Investors in AbbVie (NYSE:ABBV) have seen solid returns of 101% over the past five years. Investors in ABbVies earnings per share are down 5.3% per …

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.8909

MarketCap: 249,612,901,485.0

High: 142.37 Low: 140.98

Open: 141.89 Close: 141.2 Change: -0.69

October 27, 2023 19:21 (London Time)

AbbVie

AbbVie expects full-year earnings in the range of $11.19 to $11.23 per share. Upadacitinib has been approved in the United States for use in seven i…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9801

MarketCap: 256,284,777,936.0

High: 143.0 Low: 136.03

Open: 138.77 Close: 137.27 Change: -1.5

October 16, 2023 1:03 (London Time)

AbbVie

AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked sites. The Yes l…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9862

MarketCap: 261,156,306,772.0

High: 149.66 Low: 147.34

Open: 148.95 Close: 147.96 Change: -0.99

October 10, 2023 15:36 (London Time)

AbbVie

AbbVie Inc. (ABBV) stock price, quote, news & analysis. Use the Yes link below to take you out of the Abbvie family of websites. The inclusion of an…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9809

MarketCap: 263,186,110,454.0

High: 149.54 Low: 148.04

Open: 149.39 Close: 148.78 Change: -0.61

September 30, 2023 8:35 (London Time)

AbbVie

AbbVie Inc. stock falls t Tuesday, still outperforms market - marketwatch.com. European Commission grants conditional marketing authorization for TE…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9824

MarketCap: 263,097,858,120.0

High: 152.53 Low: 148.83

Open: 152.46 Close: 149.06 Change: -3.4

September 15, 2023 0:13 (London Time)

AbbVie

AbbVie Inc. stock has fallen -0.05% while the S&P 500 gained as of 10:56 AM on Monday, Sep 11. Skyrizi (risankizumab) met the primary and key second…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9959

MarketCap: 266,804,456,148.0

High: 154.69 Low: 151.81

Open: 152.01 Close: 153.64 Change: 1.63

August 31, 2023 5:00 (London Time)

AbbVie

AbbVie stock price is 11324% away from the 52-week low. The analysts have a median target of 16240, with a median of a high estimate of 200.00. The …

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9856

MarketCap: 261,791,723,577.0

High: 148.8 Low: 146.9

Open: 148.12 Close: 148.32 Change: 0.2

August 27, 2023 3:11 (London Time)

AbbVie

AbbVie trades on the NYSE under the ticker symbol ABBV. The company trades on NYSE. If you had invested in Abbvie stock at $35.12 in 2013, your retu…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9935

MarketCap: 258,914,697,489.0

High: 147.67 Low: 146.2

Open: 147.02 Close: 146.69 Change: -0.33

August 07, 2023 13:24 (London Time)

AbbVie

European Commission approved Rinvoq (upadacitinib, 45 mg induction dose, 15 mg and 30 mg maintenance doses) as the first oral Janus Kinase (JAK) inh…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9902

MarketCap: 262,067,589,067.0

High: 150.57 Low: 147.16

Open: 148.97 Close: 147.73 Change: -1.24

July 31, 2023 13:38 (London Time)

AbbVie

AbbVie Inc. (abbvie inc. (abvv) stock price, quote & news - stock analysis. In 2022, Abbvies revenue was $58.05 billion, an increase of 3.30% compar…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9907

MarketCap: 266,143,098,228.0

High: 151.76 Low: 148.56

Open: 149.92 Close: 150.85 Change: 0.93

July 27, 2023 2:19 (London Time)

AbbVie

AbbVie Inc. (ABBV) may see less pain from Humira sales decline as rival lags. The company is banking on its other immunology drugs Rinvoq and Skyriz…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9531

MarketCap: 250,352,705,592.0

High: 142.28 Low: 140.52

Open: 141.43 Close: 141.9 Change: 0.47

July 21, 2023 5:34 (London Time)

AbbVie

AbbVie (ABBVie) is attracting investor attention: here is what you should know. The company is expected to post earnings of $2.92 per share for the …

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9769

MarketCap: 250,864,349,599.0

High: 142.72 Low: 138.55

Open: 138.84 Close: 142.19 Change: 3.35

July 13, 2023 17:43 (London Time)

AbbVie

Dillards, Suzano, Atkore, Nexstar Media Group and AbbVie are part of the Zacks Screen of the Week article. Dillards (DDS), Suzano (SUZ), Atkore (ATK…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.7114

MarketCap: 238,143,821,006.0

High: 134.1 Low: 132.72

Open: 132.93 Close: 133.5 Change: 0.57

June 26, 2023 19:40 (London Time)

AbbVie

AbbVie stock sinks 5.1% premarket after Q1 profit missed expectations. European Commission approved Rinvoq as the first oral Janus Kinase (JAK) inhi…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9828

MarketCap: 239,802,253,305.0

High: 135.9 Low: 133.69

Open: 136.15 Close: 135.28 Change: -0.87

June 17, 2023 10:02 (London Time)

AbbVie

AbbVie is focused on strengthening its focus on new immunology medicines, Skyrizi and Rinvoq. Last month, the FDA approved JAK inhibitor RINVOq for …

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9876

MarketCap: 244,601,121,235.0

High: 138.92 Low: 136.49

Open: 136.7 Close: 138.64 Change: 1.94

May 30, 2023 3:52 (London Time)

AbbVie

AbbVie stock (ABBV) is a better pick than its industry peer, Eli Lilly stock (LLY) LLY stock trades at a higher valuation of 14.6x trailing revenues…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9861

MarketCap: 267,479,177,744.0

High: 139.85 Low: 137.1

Open: 138.72 Close: 137.56 Change: -1.16

May 21, 2023 5:54 (London Time)

AbbVie

AbbVie Inc. (ABBV) has been one of the stocks most watched by Zacks.com users lately. The company has gained 64% since 2019 primarily due to favorab…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9977

MarketCap: 267,479,177,744.0

High: 145.8 Low: 143.8

Open: 143.86 Close: 145.11 Change: 1.25

May 04, 2023 14:43 (London Time)

AbbVie

The average analyst consensus on ABBV stock is a Moderate Buy. The company beat sales expectations with revenue of $12.23 billion, topping estimates…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.8927

MarketCap: 260,828,119,040

High: 149.03 Low: 147.68

Open: 149.0 Close: 147.85 Change: -1.15

May 01, 2023 15:39 (London Time)

AbbVie

Revenue at North Chicago-based Abbvie dove by nearly 10% during the first few months of this year. AbbVie expects full-year earnings in the range of…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9879

MarketCap: 269,878,132,736

High: 154.16 Low: 150.82

Open: 150.84 Close: 152.98 Change: 2.14

April 22, 2023 6:39 (London Time)

AbbVie

AbbVie is a pharmaceutical giant that is building out its portfolio to look nothing like it did a decade ago. The company generated FCF of $24.2 bil…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.988

MarketCap: 286,513,987,584

High: 163.19 Low: 162.02

Open: 162.59 Close: 162.41 Change: -0.18

March 10, 2024 2:30 (London Time)

AbbVie

AbbVie CF Scholarship winners will each be awarded a total of $25,000. President and COO Robert Michael will take over Richard Gonzalezs CEO duties.

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9072

MarketCap: 315,933,760,257.0

High: 182.14 Low: 178.68

Open: 179.74 Close: 178.85 Change: -0.89

February 24, 2024 5:46 (London Time)

AbbVie

AbbVie CEO Richard Gonzalez will step down July 1. He will be replaced by the companys current president and chief operating officer Robert Michael.…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9817

MarketCap: 314,591,240,504.0

High: 178.91 Low: 177.01

Open: 177.26 Close: 178.09 Change: 0.83

February 21, 2024 9:33 (London Time)

AbbVie

Robert Michael, AbbVies president and chief operating officer, will become CEO on July 1. Robert Michael will succeed Richard Gonzalez, who has led …

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.8932

MarketCap: 310,293,201,740.0

High: 178.68 Low: 175.52

Open: 175.83 Close: 175.75 Change: -0.08

February 09, 2024 1:30 (London Time)

AbbVie

Skyrizi and Rinvoq as top TV drug ad spender in 2023. UK National Institute for Health and Care Excellence recommended Tepkinly as a third-line trea…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9861

MarketCap: 308,986,704,049.0

High: 175.91 Low: 174.3

Open: 174.35 Close: 174.79 Change: 0.44

January 30, 2024 2:48 (London Time)

AbbVie

AbbVie broke ground on a $223 million expansion of its Singapore manufacturing facility. The project is expected to create more than 100 new jobs an…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9633

MarketCap: 290,254,352,012.0

High: 166.76 Low: 163.68

Open: 165.85 Close: 163.91 Change: -1.94

January 26, 2024 21:48 (London Time)

AbbVie

AbbVie broke ground on a $223 million expansion of its Singapore manufacturing facility. The project is expected to create more than 100 new jobs an…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9842

MarketCap: 291,543,194,329.0

High: 165.86 Low: 163.5

Open: 165.27 Close: 164.4 Change: -0.87

January 23, 2024 2:45 (London Time)

AbbVie

AbbVie Inc. is committed to operating with integrity, driving innovation, transforming lives, serving our community, and embracing diversity and inc…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9926

MarketCap: 290,907,600,858.0

High: 165.45 Low: 163.76

Open: 164.44 Close: 165.39 Change: 0.95

January 18, 2024 2:34 (London Time)

AbbVie

CVS Health said on Wednesday it will remove Abbvies blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimb…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9855

MarketCap: 285,098,982,743.0

High: 162.95 Low: 161.52

Open: 161.75 Close: 162.04 Change: 0.29

January 16, 2024 13:47 (London Time)

AbbVie

AbbVie Inc. is one of the stocks most watched by Zacks.com visitors lately. The company is expected to post earnings of $2.93 per share in the curre…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9915

MarketCap: 286,723,277,170.0

High: 163.3 Low: 162.18

Open: 162.75 Close: 162.4 Change: -0.35

January 10, 2024 18:04 (London Time)

AbbVie

CVS Health said on Wednesday it will remove Abbvies blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimb…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9825

MarketCap: 286,564,378,802.0

High: 164.95 Low: 161.9

Open: 162.27 Close: 163.64 Change: 1.37

December 27, 2023 18:20 (London Time)

AbbVie

HSBC downgraded shares of AbbVie from a buy rating to a hold rating in a research report sent to investors on Monday morning. HSBC cut its holdings …

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9157

MarketCap: 272,987,396,035.0

High: 154.97 Low: 153.72

Open: 154.05 Close: 154.56 Change: 0.51

December 25, 2023 17:49 (London Time)

AbbVie

Average price target for AbbVie is $169.00, which is 9.07% higher than the current price. HSBC Analyst Rajesh Kumar downgrades Abbvie from Buy to Ho…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.91

MarketCap: 273,552,368,009.0

High: 155.46 Low: 153.09

Open: 153.29 Close: 154.94 Change: 1.65

December 19, 2023 0:11 (London Time)

AbbVie

AbbVie announced the acquisition of Cerevel Therapeutics in $8.7 billion all-cash deal. Q4 earnings are confirmed for Thursday, February 8, 2024. Th…

Sector: Biotechnology

Ticker: ABBV

Sentiment: -0.765

MarketCap: 271,963,384,330.0

High: 154.35 Low: 151.75

Open: 153.0 Close: 153.42 Change: 0.42

December 16, 2023 21:09 (London Time)

AbbVie

Goldman Sachs upgraded the pharma giant to Buy from Neutral with a 12-month price target of $173. AbbVie currently Up 11 Consecutive Days, on Pace f…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9849

MarketCap: 271,963,384,330.0

High: 155.89 Low: 153.11

Open: 154.74 Close: 154.04 Change: -0.7

December 05, 2023 6:29 (London Time)

AbbVie

AbbVie has agreed to acquire ImmunoGen and its first-in-class antibody-drug conjugate (ADC) ELAHERE (mirvetuximab soravtansine-gynx) for $10.1 billi…

Sector: Biotechnology

Ticker: ABBV

Sentiment: -0.7845

MarketCap: 254,502,219,237.0

High: 145.49 Low: 143.27

Open: 143.41 Close: 144.15 Change: 0.74

November 19, 2023 3:58 (London Time)

AbbVie

12 stock analysts on Stockchase covered Abbvie Inc. On 2023-11-17, the company will be worth watching. The current AbbVie [ ABBV ] share price is $1…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9781

MarketCap: 244,173,825,324.0

High: 138.88 Low: 137.38

Open: 138.36 Close: 138.3 Change: -0.06

November 07, 2023 1:05 (London Time)

AbbVie

Investors in AbbVies TSR for the last 5 years was 101% which exceeds the share price. Reddys (RDY), Novo Nordisk (NVO), and Ab

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9559

MarketCap: 249,612,901,485.0

High: 142.37 Low: 140.98

Open: 141.89 Close: 141.2 Change: -0.69

October 29, 2023 0:24 (London Time)

AbbVie

AbbVie expects full-year earnings in the range of $11.19 to $11.23 per share. CEO Rich Gonzalez says company was aware of potential for an ADC trans…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9398

MarketCap: 245,217,935,252.0

High: 143.0 Low: 136.03

Open: 138.77 Close: 138.93 Change: 0.16

October 24, 2023 4:16 (London Time)

AbbVie

AbbVie (ABBV) closed at $144.73, marking a -1.03% move from the previous day. The company currently carries a Zacks Rank #3. Abbvie recast historica…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9319

MarketCap: 255,455,205,996.0

High: 146.42 Low: 144.2

Open: 146.16 Close: 144.73 Change: -1.43

October 16, 2023 0:23 (London Time)

AbbVie

AbbVie Inc. (ABBV) stock price, quote & news - stock analysis. Analyst Consensus: Buy Stock Forecasts. Price Target $169.88 (14.82% upside)

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9843

MarketCap: 261,156,306,772.0

High: 149.66 Low: 147.34

Open: 148.95 Close: 147.96 Change: -0.99

October 07, 2023 7:32 (London Time)

AbbVie

AbbVie Inc. stock is lower by -1.78% while the S&P 500 has fallen by 1.49% as of 11:47 AM on Tuesday, Oct 3. Abbvie has acquired discovery-stage bio…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.3691

MarketCap: 261,650,519,843.0

High: 149.33 Low: 146.12

Open: 146.49 Close: 148.24 Change: 1.75

September 20, 2023 4:03 (London Time)

AbbVie

PBM officials say PBMs persuaded Abbvie to increase its Humira rebates. Company appears to be terminating development of two Phase I antibody-drug c…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9573

MarketCap: 270,917,014,913.0

High: 154.64 Low: 151.6

Open: 153.89 Close: 153.49 Change: -0.4

September 01, 2023 7:26 (London Time)

AbbVie

AbbVie (ABBV) stock has fallen -0.5% while the S&P 500 is up 0.84% as of 11:13 AM on Tuesday, Aug 29. The Street downgraded Abbvie from a “b-” ratin…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.994

MarketCap: 259,391,260,092.0

High: 148.71 Low: 146.87

Open: 148.39 Close: 146.96 Change: -1.43

August 27, 2023 5:42 (London Time)

AbbVie

AbbVie Inc. is one of the stocks most watched by Zacks.com visitors lately. For the current quarter, Abbvie is expected to post earnings of $2.87 pe…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.974

MarketCap: 258,914,697,489.0

High: 147.67 Low: 146.2

Open: 147.02 Close: 146.69 Change: -0.33

August 22, 2023 4:13 (London Time)

AbbVie

European Commission approves AQUIPTA for the prophylaxis of migraine in adults who have four or more migraine days per month. European Commission ap…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.96

MarketCap: 265,004,108,535.0

High: 150.35 Low: 148.88

Open: 149.71 Close: 150.16 Change: 0.45

August 05, 2023 14:48 (London Time)

AbbVie

European Commission approved Rinvoq as the first oral Janus Kinase (JAK) inhibitor for the treatment of adult patients with Crohns disease. Teva Pha…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9857

MarketCap: 262,067,589,067.0

High: 150.57 Low: 147.16

Open: 148.97 Close: 147.73 Change: -1.24

July 28, 2023 0:38 (London Time)

AbbVie

RINVOQ is a selective JAK inhibitor that is being studied in several immune-mediated inflammatory diseases. European Medicines Agencies Committee fo…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9557

MarketCap: 250,352,705,592.0

High: 151.37 Low: 144.12

Open: 144.48 Close: 148.85 Change: 4.37

July 24, 2023 16:03 (London Time)

AbbVie

AbbVie closed the most recent trading day at $137.68, moving +0.81% from the previous trading session. The companys next earnings release is expecte…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.969

MarketCap: 253,598,998,603.0

High: 144.43 Low: 142.84

Open: 143.1 Close: 143.72 Change: 0.62

July 18, 2023 20:31 (London Time)

AbbVie

Abbvie Inc. will announce its second-quarter 2023 financial results on Thursday, July 27, 2023, before the market opens. Dillards, Suzano, ATKore, N…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.8074

MarketCap: 237,879,177,554.0

High: 137.9 Low: 134.71

Open: 134.8 Close: 136.58 Change: 1.78

June 30, 2023 16:47 (London Time)

AbbVie

AbbVie Inc (ABBV) stock is down -1.49% while the S&P 500 has risen 1.15% as of 3:04 PM on Tuesday, Jun 27. European Medicines Agencies Committee for…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9705

MarketCap: 233,944,811,568.0

High: 135.93 Low: 132.8

Open: 133.47 Close: 135.05 Change: 1.58

June 25, 2023 9:36 (London Time)

AbbVie

Wall Street analysts forecast ABBV stock price to rise over the next 12 months. Board of directors has increased its dividend by 270 percent since i…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9907

MarketCap: 239,802,253,305.0

High: 138.69 Low: 135.67

Open: 137.3 Close: 135.92 Change: -1.38

June 03, 2023 14:16 (London Time)

AbbVie

AstraZeneca (AZN.L) said on Thursday it would stop developing its drug brazikumab. AbbVie stock forecasts short-term for next days and weeks may dif…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.2665

MarketCap: 235,426,814,899.0

High: 136.97 Low: 133.5

Open: 133.71 Close: 136.87 Change: 3.16

May 23, 2023 3:03 (London Time)

AbbVie

AbbVie Inc. reported revenues of $12.23 billion in the last reported quarter, representing a year-over-year change of -9.7%.

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9353

MarketCap: 267,479,177,744.0

High: 146.66 Low: 143.78

Open: 145.47 Close: 144.9 Change: -0.57

May 10, 2023 9:59 (London Time)

AbbVie

Guggenheim has decided to maintain their Buy rating on Abbvie, which currently sits at a price target of $171.00. Morgan Stanley has decided AbbVie …

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9874

MarketCap: 267,479,177,744.0

High: 148.46 Low: 146.27

Open: 147.41 Close: 146.83 Change: -0.58

May 03, 2023 22:57 (London Time)

AbbVie

AbbVie Inc. reports 9.7% fall in global net revenues for q1 2022. The company trimmed its full-year profit expectations earlier this month by 8 cent…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9843

MarketCap: 263,297,892,352

High: 151.51 Low: 148.45

Open: 151.07 Close: 149.25 Change: -1.82

April 28, 2023 19:21 (London Time)

AbbVie

AbbVie beat sales expectations with revenue of $12.23 billion, topping estimates of $13.17 billion. European Commission Approval of RINVOQ for the T…

Sector: Biotechnology

Ticker: ABBV

Sentiment: 0.9813

MarketCap: 266,120,527,872

High: 151.39 Low: 147.45

Open: 147.97 Close: 150.85 Change: 2.88

Happening Now

The Best Stock Graphs and Charts

AbbVie

Ticker: ABBV

Sector: Biotechnology

AbbVie

Related Results

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie

AbbVie